News Focus
News Focus
Followers 842
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

Re: Rocky3 post# 10767

Tuesday, 07/30/2013 12:07:39 PM

Tuesday, July 30, 2013 12:07:39 PM

Post# of 20689
I agree. If MNTA and MYL were hypothetically to receive FDA approval for Copaxone on the same day, I think MNTA’s share price would finish the day lower than it started. That said, I don’t expect MYL to receive approval as quickly as MNTA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”